Skip to main content
Clinical Trials/ACTRN12609000751279
ACTRN12609000751279
Completed
未知

The efficacy and safety of acupuncture for seasonal allergic rhinitis: a prospective, randomised controlled trial

Prof. Charlie Xue0 sites138 target enrollmentAugust 28, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof. Charlie Xue
Enrollment
138
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 28, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof. Charlie Xue

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 70 inclusive; a history of at least two years of typical symptoms of SAR, or of persistent allergic rhinitis (PAR) with seasonal exacerbation, including watery rhinorrhoea, sneezing, nasal obstruction and nasal and ocular itch. Although it is common for SAR sufferers to be also sensitised to allergens such as house dust mites, seasonal worsening of symptoms markedly increases morbidity and it is considered unlikely that such worsening of symptoms during the period of high grass pollen counts would be due to PAR rather than to SAR. However, a positive skin\-prick test to rye grass pollen will be required for all participants.

Exclusion Criteria

  • History of Human immunodeficiency virus(HIV); current pregnancy or breast\-feeding; other current active respiratory diseases such as asthma, sinusitis, and rhinitis medicamentosa; pollen desensitization during the last 6 months; nasal polyposis; other structural defects of the upper respiratory tract; hepatitis B or C; and, currently use systemic corticosteroid therapy or anticoagulant medications. Respondents with atopic dermatitis and who are regularly using topical corticosteroids will also be excluded. In addition, subjects who have experienced acupuncture within the last 24 months will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials